WHO Gives Approval To Bharat Bitoech's Covaxin For Emergency Use
World Health Organisation's (WHO), Technical Advisory Group (TAG) reportedly gave Emergency Use Listing (EUL) status to Bharat Biotech's Covaxin on November 3. Covaxin has been found 77.8% effective against symptomatic COVID-19 and 65% against the new Delta Variant. The decision came after the WHO had sought more clarifications from the company on October 26. Covaxin has become the second Indian vaccine to get the status after Covishield.